contraindications from manufacturer for medications including currently taking haloperidol, artane, Phenergan (Promethazine), chlorpromazine, erythromycin, Azithromycin, clarithromycin, Ketoconazole, fluconazole, mefloquine (as prophylaxis), lumefantrine (in Coartem), quinine, Septrin
anyone seriously ill
currently taking antimalarial medicines
allergy to artemisinin drugs
pregnant women in first trimester
children under 3 months of age
reported heart condition

NCT02654912_exc_T1
Condition
contraindications
NCT02654912_exc_T2
Drug
haloperidol
NCT02654912_exc_T3
Drug
Phenergan
NCT02654912_exc_T4
Drug
Promethazine
NCT02654912_exc_T5
Drug
artane
NCT02654912_exc_T6
Drug
chlorpromazine
NCT02654912_exc_T7
Drug
erythromycin
NCT02654912_exc_T8
Drug
Azithromycin
NCT02654912_exc_T9
Drug
clarithromycin
NCT02654912_exc_T10
Drug
Ketoconazole
NCT02654912_exc_T11
Drug
fluconazole
NCT02654912_exc_T12
Drug
mefloquine
NCT02654912_exc_T13
Drug
lumefantrine
NCT02654912_exc_T14
Drug
Coartem
NCT02654912_exc_T15
Drug
quinine
NCT02654912_exc_T16
Drug
Septrin
NCT02654912_exc_T17
Scope
haloperidol, artane, Phenergan (Promethazine), chlorpromazine, erythromycin, Azithromycin, clarithromycin, Ketoconazole, fluconazole, mefloquine (as prophylaxis), lumefantrine (in Coartem), quinine, Septrin
NCT02654912_exc_T18
Condition
seriously ill
NCT02654912_exc_T19
Drug
antimalarial medicines
NCT02654912_exc_T20
Drug
artemisinin drugs
NCT02654912_exc_T21
Condition
allergy
NCT02654912_exc_T22
Condition
pregnant
NCT02654912_exc_T23
Person
women
NCT02654912_exc_T24
Condition
first trimester
NCT02654912_exc_T26
Qualifier
first trimester
NCT02654912_exc_T25
Person
children
NCT02654912_exc_T27
Value
under 3 months
NCT02654912_exc_T28
Person
age
NCT02654912_exc_T29
Condition
heart condition